Evidence map›Paper›PMID 40884652›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

ISCN and Chromoanagenesis.

Martine Doco-Fenzy, Jean-Michel Dupont, Caroline Schluth-Bolard

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Martine Doco-FenzyLaboratoire de Génétique, CHU Hôtel-Dieu, Nantes, France.
Jean-Michel DupontService de Médecine Génomique des Maladies de Système et d'Organes, AP-HP Centre-Université de Paris, Hôpital Cochin, Paris, France.
Caroline Schluth-BolardLaboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The description of chromoanagenesis phenomena is relatively recent in cytogenetics, and the transcription of this type of complex rearrangement using cytogenetic nomenclature is usually complex. An abbreviation dedicated to chromothripsis, the first described of these new types of complex rearrangement, only appeared in the International System for Human Cytogenomic Nomenclature (ISCN) in 2013. This chapter aims to summarize the way(s) of reporting complex chromosome rearrangements grouped under the name of chromoanagenesis (i.e., chromothripsis, chromoanasynthesis, or chromoplexy) in the ISCN nomenclature.

Indexed as

Chromosome AberrationsChromothripsisTerminology as TopicGene RearrangementHumansChromoanasynthesisChromoplexyChromosome pulverizationChromothripsisComplex chromosomal rearrangement (CCR)ISCN

Identifiers

PMID40884652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.